BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6257466)

  • 1. [Calcitonin as a marker for bronchial carcinoma (author's transl)].
    Gropp C; Havemann K; Pflüger KH
    Dtsch Med Wochenschr; 1980 Aug; 105(34):1175-8. PubMed ID: 6257466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidiuretic hormone in patients with bronchial carcinoma (author's transl)].
    Gropp C; Havemann K; Kalbfleisch H; Luster W; Sosstmann H
    Dtsch Med Wochenschr; 1982 Jun; 107(25):974-7. PubMed ID: 6282559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum calcitonin concentration in patients with primary lung cancer].
    Kozielski J; Sledziński Z; Kokot F
    Pneumonol Pol; 1983 Dec; 51(12):627-32. PubMed ID: 6322139
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
    Feintrenie X; Briancon S; Pichene M; Lamy P
    Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytostatic therapy of bronchial carcinoma].
    Dold U
    Minerva Med; 1973 Oct; 64(76):3988-90. PubMed ID: 4357942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy of bronchial carcinoma (author's transl)].
    Debevec M; Klevisar M
    Plucne Bolesti Tuberk; 1981; 33(4):238-44. PubMed ID: 6285404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Review of today's treatment of bronchial small cell anaplastic cancers (author's transl)].
    Irisson M; Boutin C
    Poumon Coeur; 1980; 36(3):197-205. PubMed ID: 6253976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunologic evaluation of the prognosis and effective therapy of patients with small cell lung cancer].
    Ausekar BP6 ; Smirnova KD; Gromova NV; Perevodchikova NI
    Med Radiol (Mosk); 1985 Nov; 30(11):18-20. PubMed ID: 2999553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of plasmatic concentration of fibronectin in patients with bronchial carcinoma].
    Leonardo E; Mancuso M; Sanfilippo B; Dogliotti C; Scagliola D; Oliaro A
    Minerva Med; 1985 May; 76(19-20):933-5. PubMed ID: 2987760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of calcitonin and 6-oxo-prostaglandin Fl alpha in the differentiation of lung cancers].
    Burghuber OC; Kovarik J; Woloszczuk W; Sehnal E; Sinzinger H; Weissel M
    Acta Med Austriaca; 1987; 14(2):47-50. PubMed ID: 2820176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of chemotherapy in the treatment of bronchopulmonary neoplasms].
    Kenis Y; Rozencweig M
    Brux Med; 1975 Sep; 55(9):463-71. PubMed ID: 182327
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous cell carcinoma of the lung in a patient treated for small cell carcinoma. Does chemotherapy encourage the development of histologically different tumour? (author's transl)].
    Cordier JF; Touraine R
    Nouv Presse Med; 1981 May; 10(21):1713-6. PubMed ID: 6262712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
    Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL
    J Med; 1973; 4(2):96-105. PubMed ID: 4127138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of bronchial cancer].
    Schulz V
    Med Welt; 1981 Jul; 32(27):1089-98. PubMed ID: 6267409
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systematic evaluation of 8 arginine vasopressin and neurophysins plasma levels in 10 patients with oat cells carcinoma of the lung (author's transl)].
    Conte-Devolx B; Legros JJ; Poirier R; Giraud P; Gillioz P; Oliver C
    Poumon Coeur; 1979; 35(4):201-4. PubMed ID: 228260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung.
    Wallach SR; Royston I; Taetle R; Wohl H; Deftos LJ
    J Clin Endocrinol Metab; 1981 Sep; 53(3):602-6. PubMed ID: 6267098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the lung with marked hyperamylasemia and elevated serum calcitonin.
    Roberts I; Chopra S; Warshaw AL
    Am J Gastroenterol; 1982 Jan; 77(1):43-4. PubMed ID: 6175207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer].
    Maréchal F; Deltour G; Incatasciato C; Carpentier Y; Cattan A
    Rev Pneumol Clin; 1987; 43(5):224-8. PubMed ID: 2829332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.